Literature DB >> 29459494

A dual-mode hemispherical sparse array for 3D passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device.

Calum Crake1, Spencer T Brinker, Christian M Coviello, Margaret S Livingstone, Nathan J McDannold.   

Abstract

Previous work has demonstrated that passive acoustic imaging may be used alongside MRI for monitoring of focused ultrasound therapy. However, past implementations have generally made use of either linear arrays originally designed for diagnostic imaging or custom narrowband arrays specific to in-house therapeutic transducer designs, neither of which is fully compatible with clinical MR-guided focused ultrasound (MRgFUS) devices. Here we have designed an array which is suitable for use within an FDA-approved MR-guided transcranial focused ultrasound device, within the bore of a 3 Tesla clinical MRI scanner. The array is constructed from 5  ×  0.4 mm piezoceramic disc elements arranged in pseudorandom fashion on a low-profile laser-cut acrylic frame designed to fit between the therapeutic elements of a 230 kHz InSightec ExAblate 4000 transducer. By exploiting thickness and radial resonance modes of the piezo discs the array is capable of both B-mode imaging at 5 MHz for skull localization, as well as passive reception at the second harmonic of the therapy array for detection of cavitation and 3D passive acoustic imaging. In active mode, the array was able to perform B-mode imaging of a human skull, showing the outer skull surface with good qualitative agreement with MR imaging. Extension to 3D showed the array was able to locate the skull within  ±2 mm/2° of reference points derived from MRI, which could potentially allow registration of a patient to the therapy system without the expense of real-time MRI. In passive mode, the array was able to resolve a point source in 3D within a  ±10 mm region about each axis from the focus, detect cavitation (SNR ~ 12 dB) at burst lengths from 10 cycles to continuous wave, and produce 3D acoustic maps in a flow phantom. Finally, the array was used to detect and map cavitation associated with microbubble activity in the brain in nonhuman primates.

Entities:  

Mesh:

Year:  2018        PMID: 29459494      PMCID: PMC5881002          DOI: 10.1088/1361-6560/aab0aa

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  54 in total

1.  MR-guided focused ultrasound surgery.

Authors:  H E Cline; J F Schenck; K Hynynen; R D Watkins; S P Souza; F A Jolesz
Journal:  J Comput Assist Tomogr       Date:  1992 Nov-Dec       Impact factor: 1.826

2.  Effects of insertion conditions on tissue strain and vascular damage during neuroprosthetic device insertion.

Authors:  C S Bjornsson; S J Oh; Y A Al-Kofahi; Y J Lim; K L Smith; J N Turner; S De; B Roysam; W Shain; S J Kim
Journal:  J Neural Eng       Date:  2006-06-21       Impact factor: 5.379

Review 3.  MR thermometry.

Authors:  Viola Rieke; Kim Butts Pauly
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

4.  Passive cavitation imaging with ultrasound arrays.

Authors:  Vasant A Salgaonkar; Saurabh Datta; Christy K Holland; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2009-12       Impact factor: 1.840

5.  Registration of human skull computed tomography data to an ultrasound treatment space using a sparse high frequency ultrasound hemispherical array.

Authors:  Meaghan A O'Reilly; Ryan M Jones; Gabriel Birman; Kullervo Hynynen
Journal:  Med Phys       Date:  2016-09       Impact factor: 4.071

6.  Thin-film sparse boundary array design for passive acoustic mapping during ultrasound therapy.

Authors:  Christian M Coviello; Richard J Kozick; Andrew Hurrell; Penny Probert Smith; Constantin-C Coussios
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2012-10       Impact factor: 2.725

7.  Combined passive acoustic mapping and magnetic resonance thermometry for monitoring phase-shift nanoemulsion enhanced focused ultrasound therapy.

Authors:  Calum Crake; F Can Meral; Mark T Burgess; Iason T Papademetriou; Nathan J McDannold; Tyrone M Porter
Journal:  Phys Med Biol       Date:  2017-07-13       Impact factor: 3.609

8.  Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Authors:  Kullervo Hynynen; Nathan McDannold; Nickolai A Sheikov; Ferenc A Jolesz; Natalia Vykhodtseva
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

9.  MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study.

Authors:  Nir Lipsman; Michael L Schwartz; Yuexi Huang; Liesly Lee; Tejas Sankar; Martin Chapman; Kullervo Hynynen; Andres M Lozano
Journal:  Lancet Neurol       Date:  2013-03-21       Impact factor: 44.182

10.  Treatment envelope evaluation in transcranial magnetic resonance-guided focused ultrasound utilizing 3D MR thermometry.

Authors:  Henrik Odéen; Joshua de Bever; Scott Almquist; Alexis Farrer; Nick Todd; Allison Payne; John W Snell; Douglas A Christensen; Dennis L Parker
Journal:  J Ther Ultrasound       Date:  2014-10-16
View more
  11 in total

Review 1.  Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability.

Authors:  Dallan McMahon; Charissa Poon; Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2019-01-29       Impact factor: 6.648

Review 2.  Advances in acoustic monitoring and control of focused ultrasound-mediated increases in blood-brain barrier permeability.

Authors:  Ryan M Jones; Kullervo Hynynen
Journal:  Br J Radiol       Date:  2019-02-28       Impact factor: 3.039

3.  Passive Cavitation Mapping by Cavitation Source Localization From Aperture-Domain Signals-Part I: Theory and Validation Through Simulations.

Authors:  Arsenii V Telichko; Taehwa Lee; Marko Jakovljevic; Jeremy J Dahl
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-03-26       Impact factor: 2.725

Review 4.  Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.

Authors:  Scott Schoen; M Sait Kilinc; Hohyun Lee; Yutong Guo; F Levent Degertekin; Graeme F Woodworth; Costas Arvanitis
Journal:  Adv Drug Deliv Rev       Date:  2021-11-18       Impact factor: 15.470

5.  Two-step aberration correction: application to transcranial histotripsy.

Authors:  Ning Lu; Timothy L Hall; Jonathan R Sukovich; Sang Won Choi; John Snell; Nathan McDannold; Zhen Xu
Journal:  Phys Med Biol       Date:  2022-06-10       Impact factor: 4.174

6.  A theranostic 3D ultrasound imaging system for high resolution image-guided therapy.

Authors:  Hanna Bendjador; Josquin Foiret; Robert Wodnicki; Douglas N Stephens; Zoe Krut; Eun-Yeong Park; Zulma Gazit; Dan Gazit; Gadi Pelled; Katherine W Ferrara
Journal:  Theranostics       Date:  2022-06-27       Impact factor: 11.600

7.  An Ultrasound-Guided Hemispherical Phased Array for Microbubble-Mediated Ultrasound Therapy.

Authors:  Lulu Deng; Steven D Yang; Meaghan A OaReilly; Ryan M Jones; Kullervo Hynynen
Journal:  IEEE Trans Biomed Eng       Date:  2022-04-21       Impact factor: 4.756

8.  Scalp sensor for simultaneous acoustic emission detection and electroencephalography during transcranial ultrasound.

Authors:  Spencer T Brinker; Calum Crake; John R Ives; Ellen J Bubrick; Nathan J McDannold
Journal:  Phys Med Biol       Date:  2018-08-01       Impact factor: 3.609

9.  Ultrafast three-dimensional microbubble imaging in vivo predicts tissue damage volume distributions during nonthermal brain ablation.

Authors:  Ryan M Jones; Dallan McMahon; Kullervo Hynynen
Journal:  Theranostics       Date:  2020-06-01       Impact factor: 11.556

Review 10.  Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.

Authors:  Kevin Beccaria; Aria Sabbagh; John de Groot; Michael Canney; Alexandre Carpentier; Amy B Heimberger
Journal:  J Neurooncol       Date:  2020-02-28       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.